2013
DOI: 10.1172/jci65579
|View full text |Cite
|
Sign up to set email alerts
|

IgG4 subclass antibodies impair antitumor immunity in melanoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

9
211
3
2

Year Published

2013
2013
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 188 publications
(234 citation statements)
references
References 73 publications
9
211
3
2
Order By: Relevance
“…79 This report is in agreement with evidence for the presence of IgG4 antibody+ B cells in pancreatic cancer, extrahepatic cholangiocarcinoma and squamous cell carcinoma, providing evidence that this phenomenon of IgG4 impairment of the immune response in the tumor microenvironment may not be limited to melanoma. 125,126 Increased production of Th2 cytokines such as IL-4 and IL-10, has been described in the tumor microenvironment of melanoma and other cancers; [127][128][129] and IgG4, rather than IgE antibodies have been described to be elevated in individuals chronically exposed to known allergic triggers such as bee venom and animal fur.…”
Section: Ige An Antibody Class Less Prone To Tumor-induced Antibodysupporting
confidence: 90%
See 1 more Smart Citation
“…79 This report is in agreement with evidence for the presence of IgG4 antibody+ B cells in pancreatic cancer, extrahepatic cholangiocarcinoma and squamous cell carcinoma, providing evidence that this phenomenon of IgG4 impairment of the immune response in the tumor microenvironment may not be limited to melanoma. 125,126 Increased production of Th2 cytokines such as IL-4 and IL-10, has been described in the tumor microenvironment of melanoma and other cancers; [127][128][129] and IgG4, rather than IgE antibodies have been described to be elevated in individuals chronically exposed to known allergic triggers such as bee venom and animal fur.…”
Section: Ige An Antibody Class Less Prone To Tumor-induced Antibodysupporting
confidence: 90%
“…78 It is possible that these findings are due to either induction of class switching to IgE in Th2-biased milieu within the tumor microenvironment and may be indicative of a redirected, belated or inefficient immune response to cancer growth. 79,80 Nonetheless, these findings may suggest that IgE antibodies could also harbor tumor-eradicating functions. …”
Section: Allergooncology: Wielding the Allergic Response Against Cancermentioning
confidence: 99%
“…In contrast, Env-specific CD4 + T cells demonstrated much stronger and more sustained Th2 cytokine expression as compared with Gag-specific CD4 + T cells, although Th1 cytokine responses were also evident. Intriguingly, the cytokines IL-4, IL-10, and IL-13 for which we observed enhanced secretion from Env-specific CD4 + T cells in mice are associated with the induction of the inhibitory IgG4 subclass in humans (48)(49)(50)(51)(52). Unfortunately, most Th2 responses of RV138 vaccinees were below the detection limit of our assays.…”
Section: Discussionmentioning
confidence: 66%
“…With regard to IgG, the IgG4 subclass has been linked to a worse outcome and has turned out to have blocking effects on the binding of tumor-specific IgG1. 36 On the other hand, the ectopic expression of FcγRIIB, an inhibitory receptor for IgG, on melanoma cells was found to promote liver metastasis allowing the tumor to escape humoral immunity. 15 Unexpectedly, a high proportion of PCs expressed IgA.…”
Section: Discussionmentioning
confidence: 99%